Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04557995 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Erythrocytapheresis for Chronic Mountain Sickness

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv10
  2. Primary endpoints: 2 to 1v9 Show 4 more changesShow less
    • Enrollment target: 130 to 112
    • Eligibility criteria shortened, about 20 words
    • Secondary endpoints: 2 to 5
    • Study description expanded, about 24 words
  3. Primary endpoints: 1 to 2
    • Eligibility criteria shortened, about 6 words
    • Secondary endpoints: 3 to 2
    • Study description expanded, about 1 word
    v8
  4. Start date: Sep 21, 2020 to Jul 21, 2025v7 Show 6 more changesShow less
    • Primary endpoints: 2 to 1
    • Enrollment target: 100 to 130
    • Eligibility criteria expanded, about 147 words
    • Secondary endpoints revised (3)
    • Study description expanded, about 3 words
    • Study title shortened, about 3 words
  5. Primary completion date: Jan 1, 2026 to Jan 1, 2029
    • Study completion date: Oct 1, 2026 to Oct 1, 2029
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: Oct 1, 2023 to Jan 1, 2026
    • Study completion date: Oct 1, 2024 to Oct 1, 2026
    v5
  2. Primary completion date: Oct 1, 2021 to Oct 1, 2023
    • Study completion date: Oct 1, 2022 to Oct 1, 2024
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v3
  4. Eligibility criteria shortened, about 12 words
    • Secondary endpoints revised (3)
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to explore the efficacy and safety of erythrocytapheresis in chronic mountain sickness
Trial Details
NCT Number NCT04557995
Lead Sponsor Third Military Medical University
Conditions
(from sponsor)		 Chronic Mountain Sickness
Related terms Altitude Sickness
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov